Search

everythinglearnresearchcommunity

for

Search:↓

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Mesothelioma of the tunica vaginalis testis is rare, often high-grade, and has a median survival of about 24 months.

rTMS may help treat trichotillomania in some patients.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Telogen Effluvium causes increased hair shedding and can be challenging to diagnose and treat.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

N-acetylcysteine may help treat trichotillomania.

MTS effectively improves hair density and thickness in menopausal women with hair loss.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Applying thyroid hormone T3 speeds up wound healing in mice.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Some thymic peptides can increase human hair growth, while others may inhibit it.